Company profile

Circadia Health company profile

Circadia improves clinical outcomes by using an FDA-approved truly contactless patient monitoring system to detect problems early. The technology measures a patient's respiratory rate from up to 8 feet away, with nothing on the bed or body required. Clinicians use this data to forecast medical events such as congestive heart failure, COPD exacerbations, pneumonia, sepsis, urinary tract infections, and falls several hours or days in advance. To provide personalized, predictive risk alerts 24/7, a team of virtual nurses reviews device data and analyzes trends in the patient's electronic health record.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$10K+
Founded
2016-01-01

Headquarters

Headquarters
England, London, United Kingdom
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
7
Last funding
Series A / 2021-08-31
Last equity funding
Series A
Investors
5
Lead investors
2
Founders
2
Articles
8

Founders and investors

Founders

Fares SiddiquiMichal Maslik

Lead investors

SOSVVillage Global

Investors

Centregold CapitalHAXParticular VenturesSOSVVillage Global

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.